Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis

Rheumatology
P RileyC A Pilkington

Abstract

Some juvenile dermatomyositis (JDM) patients have a disease course which is refractory to multiple drug treatments. Prolonged disease activity is associated with increased mortality and morbidity. TNF-alpha has been identified in high levels in JDM patients who have a long disease course and calcinosis. We assessed the response of five refractory JDM patients to the anti-TNF-alpha monoclonal antibody, infliximab. For all five patients intravenous infliximab was initially given at a dose of 3 mg/kg. Further doses were then given at weeks 2, 6 and every 8 weeks thereafter. The dose and frequency were tailored in accordance with clinical response. Clinical and laboratory data were collected prospectively. We report results between 8 and 30 months after starting infliximab. Improvements were seen in all five patients as shown by positive changes in physician visual analogue scale (VAS), Childhood Myositis Assessment Score (CMAS), Childhood Health Assessment Questionnaire (CHAQ), joint range of movement and, in some, regression of calcinosis and skin signs. There were no major side effects observed with addition of infliximab to the therapeutic regime. Major clinical benefit was demonstrated after the initiation of infliximab in all...Continue Reading

Citations

Jul 4, 2012·Journal of Neurology·Joerg-Patrick Stübgen
Jun 27, 2013·Indian Pediatrics·Pranav R ChickermaneRaju P Khubchandani
Jun 12, 2013·American Journal of Clinical Dermatology·Alisa N FemiaJeffrey P Callen
Nov 28, 2008·Nature Clinical Practice. Rheumatology·Jakko van IngenDick van Soolingen
Sep 29, 2011·Nature Reviews. Rheumatology·Angela B Robinson, Ann M Reed
Sep 5, 2009·Current Opinion in Rheumatology·Clodagh A Lowry, Clarissa A Pilkington
Sep 20, 2011·Current Opinion in Rheumatology·Heřman F Mann, Jiří Vencovský
Jan 10, 2012·Current Opinion in Rheumatology·Sumeet Chander, Patrick Gordon
Aug 6, 2013·Current Opinion in Rheumatology·Adam Huber, Brian M Feldman
Dec 3, 2009·Plastic and Reconstructive Surgery·Agata VitaleFrancesco Stagno D'Alcontres
Aug 14, 2010·International Journal of Rheumatic Diseases·Sulaiman M Al-MayoufKhalid Alismail
Aug 8, 2012·Therapeutic Advances in Musculoskeletal Disease·Neil MartinLucy R Wedderburn
Feb 26, 2010·Pediatric Rheumatology Online Journal·Takako MiyamaeShumpei Yokota
Nov 24, 2011·Clinical & Developmental Immunology·Boel De PaepeJan L De Bleecker
Dec 19, 2012·Indian Journal of Dermatology·Aparna Palit, Arun C Inamadar
Jul 16, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Anne TournadreMartin Soubrier
Oct 7, 2014·Indian Journal of Dermatology·Virendra N SehgalAnanta Khurana
Mar 14, 2014·Archives of Disease in Childhood·Ethan S Sen, A V Ramanan
Nov 5, 2014·Current Rheumatology Reports·Mark F HoeltzelLisa G Rider
Feb 12, 2011·Current Rheumatology Reports·Michelle Batthish, Brian M Feldman
Aug 1, 2012·European Journal of Pediatrics·Seyed Behzad JazayeriAbtin Shahlaee
Mar 25, 2015·Modern Rheumatology·Asli Celebi TayfurYelda Bilginer
Aug 14, 2015·International Journal of Molecular Sciences·Boel De Paepe, Jana Zschüntzsch
Jun 10, 2011·Expert Opinion on Biological Therapy·Raj PatelJennifer A Cafardi
Nov 5, 2013·Rheumatic Diseases Clinics of North America·Lisa G RiderOlcay Y Jones
Oct 23, 2015·Indian Journal of Pediatrics·Liza J McCann, Clare E Pain
Nov 14, 2015·Seminars in Immunopathology·Natalie A WrightJeffrey P Callen
Oct 2, 2015·Seminars in Immunopathology·C Schlapbach, A A Navarini
Nov 15, 2011·Annales de dermatologie et de vénéréologie·F BayouR Nouira
Dec 21, 2010·Journal of the Neurological Sciences·T A HardyM H Barnett
Feb 1, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·Amine ZouaguiMoustapha Hida
Jun 1, 2010·Dermatologic Clinics·Joni MazzaJeffrey M Weinberg
Dec 25, 2009·Joint, Bone, Spine : Revue Du Rhumatisme·Samy SlimaniAicha Ladjouze-Rezig
Oct 27, 2009·Best Practice & Research. Clinical Rheumatology·Lucy R Wedderburn, Lisa G Rider
Jun 2, 2014·La Revue de médecine interne·B Bienvenu
Jun 30, 2012·Dermatologic Therapy·Christina Lam, Ruth Ann Vleugels
Oct 16, 2013·Arthritis Care & Research·Kelly A Rouster-StevensLauren M Pachman
Oct 3, 2015·Clinical Reviews in Allergy & Immunology·Ilaria PagniniLuca Cantarini
Jan 1, 2014·Orvosi hetilap·Levente BodokiKatalin Dankó

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.